These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23399644)

  • 1. Neuro-oncology: new therapeutic targets identified in meningiomas.
    Bible E
    Nat Rev Neurol; 2013 Mar; 9(3):121. PubMed ID: 23399644
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of novel therapeutic targets through genomic analysis of meningiomas.
    Komotar RJ; Starke RM; Connolly ES
    Neurosurgery; 2013 Aug; 73(2):N22-4. PubMed ID: 23867274
    [No Abstract]   [Full Text] [Related]  

  • 3. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.
    Brastianos PK; Horowitz PM; Santagata S; Jones RT; McKenna A; Getz G; Ligon KL; Palescandolo E; Van Hummelen P; Ducar MD; Raza A; Sunkavalli A; Macconaill LE; Stemmer-Rachamimov AO; Louis DN; Hahn WC; Dunn IF; Beroukhim R
    Nat Genet; 2013 Mar; 45(3):285-9. PubMed ID: 23334667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
    Clark VE; Erson-Omay EZ; Serin A; Yin J; Cotney J; Ozduman K; Avşar T; Li J; Murray PB; Henegariu O; Yilmaz S; Günel JM; Carrión-Grant G; Yilmaz B; Grady C; Tanrikulu B; Bakircioğlu M; Kaymakçalan H; Caglayan AO; Sencar L; Ceyhun E; Atik AF; Bayri Y; Bai H; Kolb LE; Hebert RM; Omay SB; Mishra-Gorur K; Choi M; Overton JD; Holland EC; Mane S; State MW; Bilgüvar K; Baehring JM; Gutin PH; Piepmeier JM; Vortmeyer A; Brennan CW; Pamir MN; Kiliç T; Lifton RP; Noonan JP; Yasuno K; Günel M
    Science; 2013 Mar; 339(6123):1077-80. PubMed ID: 23348505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-NF2 mutations in meningioma.
    Benmaamar R
    Lancet Oncol; 2013 Mar; 14(3):e91. PubMed ID: 23580960
    [No Abstract]   [Full Text] [Related]  

  • 6. Genomic analysis of non-neurofibromatosis type 2 meningiomas.
    Parry PV; Engh JA
    Neurosurgery; 2013 Jun; 72(6):N18-9. PubMed ID: 23685513
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway.
    Johnson MD; O'Connell MJ; Pilcher W; Reeder JE
    J Neurosurg; 2010 May; 112(5):934-9. PubMed ID: 19698046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
    Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
    Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic landscape of intracranial meningiomas.
    Bi WL; Abedalthagafi M; Horowitz P; Agarwalla PK; Mei Y; Aizer AA; Brewster R; Dunn GP; Al-Mefty O; Alexander BM; Santagata S; Beroukhim R; Dunn IF
    J Neurosurg; 2016 Sep; 125(3):525-35. PubMed ID: 26771848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline and somatic mutations in meningiomas.
    Smith MJ
    Cancer Genet; 2015 Apr; 208(4):107-14. PubMed ID: 25857641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas.
    Boetto J; Bielle F; Sanson M; Peyre M; Kalamarides M
    Neuro Oncol; 2017 Mar; 19(3):345-351. PubMed ID: 28082415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of oncogenic AKT1 E17K mutation in prostate, esophageal, laryngeal and urothelial carcinomas, hepatoblastomas, gastrointestinal stromal tumors and malignant meningiomas.
    Eom HS; Kim MS; Hur SY; Yoo NJ; Lee SH
    Acta Oncol; 2009; 48(7):1084-5. PubMed ID: 19353338
    [No Abstract]   [Full Text] [Related]  

  • 13. New molecular targets in meningiomas: the present and the future.
    Venur VA; Santagata S; Galanis E; Brastianos PK
    Curr Opin Neurol; 2018 Dec; 31(6):740-746. PubMed ID: 30379704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of the sis and c-myc oncogenes in human meningiomas.
    Kazumoto K; Tamura M; Hoshino H; Yuasa Y
    J Neurosurg; 1990 May; 72(5):786-91. PubMed ID: 2182793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic landscape of meningioma.
    Yuzawa S; Nishihara H; Tanaka S
    Brain Tumor Pathol; 2016 Oct; 33(4):237-247. PubMed ID: 27624470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.
    Abedalthagafi M; Bi WL; Aizer AA; Merrill PH; Brewster R; Agarwalla PK; Listewnik ML; Dias-Santagata D; Thorner AR; Van Hummelen P; Brastianos PK; Reardon DA; Wen PY; Al-Mefty O; Ramkissoon SH; Folkerth RD; Ligon KL; Ligon AH; Alexander BM; Dunn IF; Beroukhim R; Santagata S
    Neuro Oncol; 2016 May; 18(5):649-55. PubMed ID: 26826201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of HER-2 activity in the regulation of malignant meningioma cell proliferation and motility.
    Wang W; Tu Y; Wang S; Xu S; Xu L; Xiong Y; Mei J; Wang C
    Mol Med Rep; 2015 Sep; 12(3):3575-3582. PubMed ID: 25998419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry.
    Sahm F; Bissel J; Koelsche C; Schweizer L; Capper D; Reuss D; Böhmer K; Lass U; Göck T; Kalis K; Meyer J; Habel A; Brehmer S; Mittelbronn M; Jones DT; Schittenhelm J; Urbschat S; Ketter R; Heim S; Mawrin C; Hainfellner JA; Berghoff AS; Preusser M; Becker A; Herold-Mende C; Unterberg A; Hartmann C; Kickingereder P; Collins VP; Pfister SM; von Deimling A
    Acta Neuropathol; 2013 Nov; 126(5):757-62. PubMed ID: 24096618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of p53 gene mutation in tumor aggressiveness of intracranial meningiomas.
    Cho H; Ha SY; Park SH; Park K; Chae YS
    J Korean Med Sci; 1999 Apr; 14(2):199-205. PubMed ID: 10331568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome abnormalities in multiple meningiomas of a child.
    Wullich B; Mayfrank L; Schwechheimer K; Finke J; Schempp W
    Genes Chromosomes Cancer; 1990 Jul; 2(2):166-8. PubMed ID: 2278972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.